EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells

Rubén D Arroyo-Olarte, Juan C Flores-Castelán, Leonel Armas-López, Galileo Escobedo, Luis I Terrazas, Federico Ávila-Moreno, Sonia Leon-Cabrera

Inflammation · 2024-12 · 47 (6) · 2159-2172

DOI: 10.1007/s10753-024-02031-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, online erschienen am 03.05.2024. Verfasst von Rubén D Arroyo-Olarte und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Biomedicina. Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Av. De los Barrios 1, Los Reyes Iztacala, E…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Forkhead Transcription Factors, STAT6 Transcription Factor. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Nacional Autónoma de México, Consejo Nacional de Ciencia y Tecnología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vitro induced T regulatory cells (iTregs) are promising for addressing inflammation-driven diseases. However, current protocols for the generation and expansion of iTregs fail to induce extensive demethylation of the Treg-specific demethylated region (TSDR) within the FOXP3 gene, recognized as the master regulator for regulatory T cells (Tregs). This deficiency results in the rapid loss of Foxp3 expression and an unstable regulatory phenotype. Nevertheless, inhibition of STAT6 signaling effectively stabilizes Foxp3 expression in iTregs. Thus, this study aimed to develop a protocol combining epigenetic editing with STAT6 deficiency to improve iTregs’ ability to maintain stable suppressive function and a functional phenotype. Our findings demonstrate that the combination of STAT6 deficiency (STAT6-/-) with targeted demethylation of the TSDR using a CRISPR-TET1 tool leads to extensive demethylation of FOXP3 -TSDR. Demethylation in STAT6-/- iTregs was associated with enhanced expression of Foxp3 and suppressive markers such as CTLA-4, PD-1, IL-10, and TGF-β. Furthermore, the edited STAT6-/- iTregs exhibited an increased capacity to suppress CD8+ and CD4+ lymphocytes and could more efficiently impair Th1-signature gene expression compared to conventional iTregs. In conclusion, the deactivation of STAT6 and TSDR-targeted demethylation via CRISPR-TET1 is sufficient to induce iTregs with heightened stability and increased suppressive capacity, offering potential applications against inflammatory and autoimmune diseases .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryForkhead Transcription FactorsSTAT6 Transcription FactorAnimalsMiceDemethylation

Stichwörter der Autor:innen

CRISPR-Cas9DNA methylationFOXP3STAT6TET1Tregs

Substanzen

Forkhead Transcription FactorsSTAT6 Transcription FactorFoxp3 protein, mouseStat6 protein, mouse

Autor:innen und Institutionen

  • Unidad de Biomedicina. Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Av. De los Barrios 1, Los Reyes Iztacala, Edo. De México, Tlalnepantla, México.
  • Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Av. De los Barrios 1, Los Reyes Iztacala, Edo. De México, Tlalnepantla, México.
  • Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", 06720, Mexico City, Mexico.
  • Laboratorio Nacional en Salud, Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Edo. De México, Tlalnepantla, México.
  • Unidad de Biomedicina. Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Av. De los Barrios 1, Los Reyes Iztacala, Edo. De México, Tlalnepantla, México. soleonca@comunidad.unam.mx.
  • Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Av. De los Barrios 1, Los Reyes Iztacala, Edo. De México, Tlalnepantla, México. soleonca@comunidad.unam.mx.

Förderung

  • Universidad Nacional Autónoma de México
  • Consejo Nacional de Ciencia y Tecnología

Zitieren

APA

Arroyo-Olarte, R. D., Flores-Castelán, J. C., Armas-López, L., Escobedo, G., Terrazas, L. I., Ávila-Moreno, F., & Leon-Cabrera, S. (2024). Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells. Inflammation, 47(6), 2159-2172. https://doi.org/10.1007/s10753-024-02031-4

Vancouver

Arroyo-Olarte RD, Flores-Castelán JC, Armas-López L, Escobedo G, Terrazas LI, Ávila-Moreno F, et al. Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells. Inflammation. 2024;47(6):2159-2172. doi:10.1007/s10753-024-02031-4

BibTeX
@article{ArroyoOlarte2024,
  author = {Arroyo-Olarte, Rubén D and Flores-Castelán, Juan C and Armas-López, Leonel and Escobedo, Galileo and Terrazas, Luis I and Ávila-Moreno, Federico and Leon-Cabrera, Sonia},
  title = {Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells},
  journal = {Inflammation},
  year = {2024},
  volume = {47},
  number = {6},
  pages = {2159--2172},
  doi = {10.1007/s10753-024-02031-4}
}
Kostenlos starten →